(Q48561405)

12 February 2018

title

Prediction, progression and prevention of diabetic nephropathy. The Minkowski Lecture 2005. (English)

1 reference

12 February 2018

author name string

P Rossing

series ordinal

1

1 reference

12 February 2018

publication date

9 December 2005

1 reference

12 February 2018

published in

Diabetologia

1 reference

12 February 2018

volume

49

1 reference

12 February 2018

issue

1

1 reference

12 February 2018

page(s)

11-19

1 reference

12 February 2018

https://scigraph.springernature.com/pub.10.1007/s00125-005-0077-3

exact match

0 references

cites work

Congenital oligonephropathy and the etiology of adult hypertension and progressive renal injury

1 reference

https://api.crossref.org/works/10.1007%2FS00125-005-0077-3

Short stature and diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-005-0077-3

Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-005-0077-3

Randomised controlled trial of long term efficacy of captopril on preservation of kidney function in normotensive patients with insulin dependent diabetes and microalbuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-005-0077-3

Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-005-0077-3

Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-005-0077-3

Glomeruli and blood pressure. Less of one, more the other?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-005-0077-3

A nonlinear effect of hyperglycemia and current cigarette smoking are major determinants of the onset of microalbuminuria in type 1 diabetes

21 January 2018

1 reference

12 December 2020

Plasma prorenin as an early marker of nephropathy in diabetic (IDDM) adolescents

1 reference

12 December 2020

Biochemical risk markers: a novel area for better prediction of renal risk?

1 reference

12 December 2020

Insulin resistance in insulin-dependent diabetic patients with microalbuminuria

1 reference

12 December 2020

Dual blockade of the renin-angiotensin system in diabetic nephropathy: a randomized double-blind crossover study

1 reference

12 December 2020

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

1 reference

12 December 2020

Is diabetic nephropathy an inherited complication?

1 reference

12 December 2020

Nephropathy in type 1 diabetes: a manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study

1 reference

12 December 2020

Dual blockade of the renin-angiotensin system versus maximal recommended dose of ACE inhibition in diabetic nephropathy

1 reference

12 December 2020

Smoking and Progression of Diabetic Nephropathy in Type 1 Diabetes

1 reference

12 December 2020

Predicting diabetic nephropathy in insulin-dependent patients

1 reference

12 December 2020

Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy

1 reference

12 December 2020

Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study

1 reference

12 December 2020

Long-term juvenile diabetes treated with unmeasured diet

1 reference

12 December 2020

Improved prognosis in type 1 diabetic patients with nephropathy: a prospective follow-up study

1 reference

12 December 2020

Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation

1 reference

12 December 2020

Smoking is associated with progression of diabetic nephropathy

1 reference

12 December 2020

Captopril and atenolol are equally effective in retarding progression of diabetic nephropathy. Results of a 2-year prospective, randomized study

1 reference

12 December 2020

Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial

1 reference

12 December 2020

Renoprotection in diabetes: genetic and non-genetic risk factors and treatment

1 reference

12 December 2020

The changing epidemiology of diabetic microangiopathy in type 1 diabetes.

1 reference

12 December 2020

Impact of Arterial Blood Pressure and Albuminuria on the Progression of Diabetic Nephropathy in IDDM Patients

1 reference

12 December 2020

Dual blockade of the renin-angiotensin system in type 1 patients with diabetic nephropathy

1 reference

12 December 2020

Progression of nephropathy in long-term diabetics with proteinuria and effect of initial anti-hypertensive treatment

1 reference

12 December 2020

Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes--the EURODIAB Prospective Complications Study

1 reference

12 December 2020

Monitoring glomerular function in diabetic nephropathy. A prospective study

1 reference

12 December 2020

Impact of diabetic nephropathy and angiotensin II receptor blockade on urinary polypeptide patterns

1 reference

12 December 2020

Rise in albuminuria and blood pressure in patients who progressed to diabetic nephropathy in the Diabetes Control and Complications Trial

1 reference

12 December 2020

von Willebrand factor and development of diabetic nephropathy in IDDM.

1 reference

12 December 2020

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

1 reference

12 December 2020

Progression of microalbuminuria in type 1 diabetes: ten-year prospective observational study

1 reference

12 December 2020

Long-term renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype?

1 reference

12 December 2020

Cigarette smoking increases the risk of albuminuria among subjects with type I diabetes

1 reference

12 December 2020

Familial Clustering of Cardiovascular Disease in Patients with Insulin-Dependent Diabetes and Nephropathy

1 reference

12 December 2020

A prospective study of glomerular filtration rate and arterial blood pressure in insulin-dependent diabetics with diabetic nephropathy

1 reference

12 December 2020

Diabetic nephropathy in type 1 (insulin-dependent) diabetes: An epidemiological study

1 reference

12 December 2020

Predictors of microalbuminuria in individuals with IDDM. Pittsburgh Epidemiology of Diabetes Complications Study

1 reference

12 December 2020

Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy

1 reference

12 December 2020

Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion

1 reference

12 December 2020

Biochemistry and molecular cell biology of diabetic complications

1 reference

12 December 2020

Diabetic nephropathy. Pathogenetic aspects and cardiovascular risk factors

1 reference

12 December 2020

Prevention of diabetic renal disease with special reference to microalbuminuria

1 reference

12 December 2020

The predictive value of microalbuminuria in IDDM. A five-year follow-up study

1 reference

12 December 2020

Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation

1 reference

12 December 2020

Angiotensin converting enzyme gene polymorphism predicts blood pressure response to angiotensin II receptor type 1 antagonist treatment in hypertensive patients

1 reference

12 December 2020

Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes

1 reference

12 December 2020

The acute effect of smoking on systemic haemodynamics, kidney and endothelial functions in insulin-dependent diabetic patients with microalbuminuria

1 reference

12 December 2020

Microalbuminuria in type 1 diabetes: rates, risk factors and glycemic threshold

1 reference

12 December 2020

The early natural history of nephropathy in Type 1 Diabetes: III. Predictors of 5-year urinary albumin excretion rate patterns in initially normoalbuminuric patients

1 reference

12 December 2020

Mannose-binding lectin as a predictor of microalbuminuria in type 1 diabetes: an inception cohort study

1 reference

12 December 2020

Intensive therapy and progression to clinical albuminuria in patients with insulin dependent diabetes mellitus and microalbuminuria. Microalbuminuria Collaborative Study Group, United Kingdom

1 reference

12 December 2020

Pathways for angiotensin II generation in intact human tissue: evidence from comparative pharmacological interruption of the renin system

1 reference

12 December 2020

Long-term dual blockade with candesartan and lisinopril in hypertensive patients with diabetes: the CALM II study.

1 reference

12 December 2020

Benefits of long-term antihypertensive treatment on prognosis in diabetic nephropathy

1 reference

12 December 2020

Preventing end stage renal disease in diabetic patients--genetic aspect (part I).

1 reference

12 December 2020

Albuminuria and Poor Glycemic Control Predict Mortality in NIDDM

1 reference

12 December 2020

Promotion, prediction and prevention of progression of nephropathy in type 1 diabetes mellitus

1 reference

12 December 2020

Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. The Diabetes Control and Complications (DCCT) Research Group

1 reference

12 December 2020

The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient?

1 reference

12 December 2020

Renal protective effect of enalapril in diabetic nephropathy

1 reference

12 December 2020

Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes.

1 reference

12 December 2020

Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy

1 reference

12 December 2020

Low Birth Weight: A Risk Factor for Development of Diabetic Nephropathy?

1 reference

12 December 2020

Renal mRNA levels as prognostic tools in kidney diseases.

1 reference

12 December 2020

Predictive value of microalbuminuria in patients with insulin-dependent diabetes of long duration

1 reference

12 December 2020

Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus

1 reference

12 December 2020

Oral contraceptives, angiotensin-dependent renal vasoconstriction, and risk of diabetic nephropathy

1 reference

12 December 2020

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

Cardiovascular morbidity and early mortality cluster in parents of type 1 diabetic patients with diabetic nephropathy

1 reference

12 December 2020

Progression of diabetic nephropathy

1 reference

12 December 2020

Relationship between blood pressure and urinary albumin excretion in development of microalbuminuria

1 reference

12 December 2020

Preventing diabetic nephropathy: an audit

1 reference

12 December 2020

Effectiveness of aldosterone blockade in patients with diabetic nephropathy

1 reference

12 December 2020

Optimal dose of candesartan for renoprotection in type 2 diabetic patients with nephropathy: a double-blind randomized cross-over study

1 reference

12 December 2020

Optimal dose of losartan for renoprotection in diabetic nephropathy

1 reference

12 December 2020

Beneficial impact of spironolactone in diabetic nephropathy

1 reference

12 December 2020

Progression of microalbuminuria to proteinuria in type 1 diabetes: nonlinear relationship with hyperglycemia

1 reference

12 December 2020

Oral contraceptive use and hormone replacement therapy are associated with microalbuminuria

1 reference

12 December 2020

Factors associated with progression to macroalbuminuria in microalbuminuric Type 1 diabetic patients: the EURODIAB Prospective Complications Study

1 reference

12 December 2020

Ambulatory blood pressure in microalbuminuric type 1 diabetic patients

1 reference

12 December 2020

The changing natural history of nephropathy in type I diabetes

1 reference

12 December 2020

Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus

1 reference

12 December 2020

Microalbuminuria: associations with height and sex in non-diabetic subjects

1 reference

12 December 2020

Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study

1 reference

12 December 2020

Predictors of the development of microalbuminuria in patients with Type 1 diabetes mellitus: a seven-year prospective study. The Microalbuminuria Collaborative Study Group

1 reference

12 December 2020

The natural course of microalbuminuria in insulin-dependent diabetes: a 10-year prospective study.

1 reference

12 December 2020

Epidemiology of persistent proteinuria in type II diabetes mellitus. Population-based study in Rochester, Minnesota

1 reference

12 December 2020

Genetic variation in the Renin-Angiotensin system and progression of diabetic nephropathy

1 reference

12 December 2020

Aldosterone and the hypertensive kidney: its emerging role as a mediator of progressive renal dysfunction: a paradigm shift

1 reference

12 December 2020

Low birth weight, nephron number, and kidney disease.

1 reference

12 December 2020

Enhanced renoprotective effects of ultrahigh doses of irbesartan in patients with type 2 diabetes and microalbuminuria

1 reference

12 December 2020

Meta analysis. Diabetic nephropathy and the insertion/deletion polymorphism of the angiotensin-converting enzyme gene

1 reference

12 December 2020

Aldosterone escape during blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate.

1 reference

12 December 2020

Reversal of lesions of diabetic nephropathy after pancreas transplantation

1 reference

12 December 2020

Significance of microalbuminuria in long-duration type 1 diabetes

1 reference

12 December 2020

Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes

1 reference

12 December 2020

Risk factors for development of incipient and overt diabetic nephropathy in type 1 diabetic patients: a 10-year prospective observational study

1 reference

12 December 2020

Regression of microalbuminuria in type 1 diabetes

1 reference

12 December 2020

Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment

1 reference

12 December 2020

Long-term renoprotective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy

1 reference

12 December 2020

Increase in serum prorenin precedes onset of microalbuminuria in patients with insulin-dependent diabetes mellitus

1 reference

12 December 2020

Angiotensin type 2 receptor antagonism confers renal protection in a rat model of progressive renal injury

1 reference

12 December 2020

Albumin excretion and vascular deaths in NIDDM

1 reference

12 December 2020

Beneficial effects of adding spironolactone to recommended antihypertensive treatment in diabetic nephropathy: a randomized, double-masked, cross-over study

1 reference

12 December 2020

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

12 December 2020

Meta-analysis of effects of intensive blood-glucose control on late complications of type I diabetes

1 reference

12 December 2020

10.1007/S00125-005-0077-3

Identifiers

DOI

1 reference

12 February 2018

1 reference

12 February 2018